Professor Andrew J Krentz
MB ChB, MD, FRCP, FFPM, FRSA
Visiting Professor of Medical Science
Institute of Cardiovascular & Metabolic Research, University of Reading, UK
Visiting Professor in Population Health Sciences
Faculty of Life Sciences & Medicine, King’s College London, UK
Consultant Physician in Endocrinology, Diabetes & Cardiovascular Medicine
Centre for Men’s Health, London, UK
Director of Cardiometabolic Division
Metadvice, London, UK
Visiting Senior Research Fellow
ProSciento, San Diego, USA
Andrew has four decades of clinical and translational research experience in metabolic, endocrine, and related cardiovascular disorders. He is recognized as a clinical academic and thought leader. Andrew is active in undergraduate and postgraduate medical education at national and international level.
He graduated in medicine (MB ChB) from the University of Birmingham, UK and completed his postgraduate training in diabetes, endocrinology, and human metabolism in the UK and His MD clinical research thesis was titled Metabolic Studies in Insulin Resistance.
Andrew’s expertise in the life sciences includes preclinical and early-phase clinical diabetes drug development. He is credited with pioneering innovations in endocrinology clinical practice and metabolic research methodologies. His current projects are focused on precision therapeutics in diabetes and cardiometabolic medicine. Andrew’s medical practice aims to translate science into best personalized care. In addition to his expertise in diabetes & endocrinology he is accredited as a clinical specialist in hypertension by the European Hypertension Society.